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Telomeres are the end fragments of chromosomes formed by a number of
non-coding double-stranded TTAGGG repeats in vertebrates. During cell divi-
sion the number of repeats decreases, leading to cell senescence or apoptosis.
In immortal cells, including cancer cells, the telomere length is stable and main-
tained by, among other factors, telomerase. The aim of the study is to com-
pare telomerase activity in normal lymphocytes and in leukaemic cells. Sam-
ples of acute leukaemia cells, HL 60 cell line and the lymphocytes of healthy
volunteers were examined. Telomerase analysis was performed using TeloTAGGG
Telomerase PCR ELISAplus (Roche). The relative telomerase activities (RTA)
in leukaemic and normal cells were analysed. A high level of RTA was observed
in leukaemic cells.
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INTRODUCTION
One of the functions of telomeres, the end frag-
ments of chromosomes formed by a number of non-
coding double-stranded TTAGGG repeats in verte-
brates, is the protection of chromosome ends from
inappropriate DNA repair mechanisms [1]. During
cell division the number of repeats decreases (at
a rate of about 150 nucleotides per division), lead-
ing to cell senescence or apoptosis [3]. In immortal
cells, including cancer cells, the telomere length is
stable and maintained by a number of telomere pro-
tection mechanisms. Probably the most important
of these mechanisms is telomerase [5]. This enzyme
is able to maintain a sufficient number of telomeric
repeats for cell survival [8]. Leukaemic cells, includ-
ing ALL, ANLL-M1, CLL and CML, have, in a number
of studies, shown higher telomerase activity than the
control lymphocytes [2, 6].
The aim of the study is to compare telomerase
activity in normal lymphocytes with that in  leukaemic
cells (HL-60 cell line, AML and APL).
MATERIAL AND METHODS
Bone marrow cells were obtained from 3 patients
with suspected acute myeloid leukaemia from the
Department of Haematology of the Medical Univer-
sity of Lublin. Cells were also obtained from human
HL-60 leukaemic cell line and normal peripheral blood
lymphocytes were obtained from 3 healthy volun-
teers.
Telomerase analysis was performed using TeloT-
AGGG Telomerase PCR ELISAplus (Roche). Cells were
counted 2 × 105 per single reaction and were pel-
leted at 3000xg for 5 min at 4oC. The cells were
suspended in PBS and the centrifugation step was
repeated. The pelleted cells were then resuspend-
ed in Lysis reagent and were incubated on ice for
30 min. The lysate was centrifuged at 16000xg for
20 min at 4oC and 3 µl cell extract was added to the
PCR tubes. For each sample tested and the control
template 25 µl Reaction mixture (containing bioti-
nylated telomerase substrate P1-TS, optimised an-
chor primer P2, nucleotides and Taq DNA poly-
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merase) and 5 µl of the Internal Standard were trans-
ferred into the PCR tubes. Negative controls were pre-
pared by heat treatment of cell extracts for 10 min
in 85oC. The control template was prepared by add-
ing commercial control template and Lysis reagent
into 2 separate tubes. PCR were performed in Perk-
inElmer 2400 Thermal Cycler: 30 cycles — 94oC for
30 s, 50oC for 30 s and 72oC for 90 s. The amplifica-
tion product was added to 2 separate tubes con-
taining 10 µl of denaturation reagent. 100 µl hy-
bridisation buffer T was added to one vial and 100
µl hybridisation buffer IS was added to the other.
Each mixture was transferred into pre-coated MTP
modules, incubated in 37oC for 2 h, washed and
incubated with 100 µl Anti-DIG-HRP. MTP modules
were incubated at 20oC for 30 min and 100 µl TMB
was added for colour development. The absorbance
of the samples was measured at 450 nm (with
a reference wavelength of 620 nm) using a Micro-
titer plate (ELISA) reader. The relative telomerase
activities (RTA) were obtained using the following
formula:
RTA = [(AS–AS0):AS,IS]:[(ATS8 – ATS8,0):ATS8,IS] × 100
(AS — absorbance of sample, AS0 — absorbance of
heat- or Rnase-treated sample, AS,IS — absorbance
of internal standard (IS) of the sample, ATS8 — ab-
sorbance of control template (TS8), ATS8,0 — absor-
bance of Lysis buffer, ATS8,IS — absorbance of inter-
nal standard (IS) of the control template (TS8).
RESULTS
The relative telomerase activities (RTA) in leu-
kaemic and normal cells were analysed (Table 1).
A high level of RTA was observed in leukaemic cells.
DISCUSSION
As it was mentioned above, telomerase is
present in human germ cell lines (testis and ovary),
cancer cells and immortal cell lines. However, it has
not been detected in normal adult somatic tissues
or cultured human diploid cells, with the exception
of renewal tissues that contain stem cells (e.g.
blood, skin and intestine) [3, 4]. Immortal cells, in-
cluding cancer cells, avoid the progressive loss of
telomeric DNA by expressing telomerase. Surpris-
ingly, while cancer cells have high levels of telom-
erase, their telomeres are generally short, although
their length remains stable [5]. Reactivation of te-
lomerase activity may be the critical, if not rate lim-
iting step in the development of neoplasmatic cells
[5]. The previous studies of the leukaemic cells men-
tioned above [2, 6, 7] have demonstrated signifi-
cantly higher telomerase activity than in normal lym-
phocytes. The results of this study confirm these
findings. Thus we may conclude that telomerase
activity is worth further investigation as one of the
markers of tumour development.
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Table 1. The relative telomerase activities
Sample Origin RTA
1 Acute promyelocytic leukaemia 14,400.0
2 Acute promyelocytic leukaemia 16,440.0
3 Acute myeloid leukaemia 10,600.0
with t(8;21)
4 HL-60 cell line 9,010.0
5 Healthy donor 112.5
6 Healthy donor 117.5
7 Healthy donor 168.8
